NdowaFJFrancisJMMachihaA, et al.Gonococcal antimicrobial resistance: perspectives from the African region. Sex Transm Infect2013; 89(Suppl 4): iv11–iv15.
2.
Van DyckEKaritaEAbdellatiS, et al.Antimicrobial susceptibilities of Neisseria gonorrhoeae in Kigali, Rwanda, and trends of resistance between 1986 and 2000. Sex Transm Dis2001; 28(9): 539–545.
3.
MoodleyPSturmAW. Ciprofloxacin-resistant gonorrhoea in South Africa. Lancet2005; 366(9492): 1159.
4.
MadunaLDKockMMvan der VeerB, et al.Antimicrobial resistance of Neisseria gonorrhoeae isolates from high-risk Men in Johannesburg, South Africa. Antimicrob Agents Chemother2020; 64(11); e00906-20.
5.
JumaMSankaradossANdombiR, et al.Antimicrobial resistance profiling and phylogenetic analysis of Neisseria gonorrhoeae clinical isolates from Kenya in a resource-limited setting. Front Microbiol2021; 12: 647565.
6.
MabongaEParkes-RatanshiRRiedelS, et al.Complete ciprofloxacin resistance in gonococcal isolates in an urban Ugandan clinic: findings from a cross-sectional study. Int J STD AIDS2019; 30(3): 256–263.
7.
Van DyckECrabbéFNzilaN, et al.Increasing resistance of Neisseria gonorrhoeae in west and central Africa. Consequence on therapy of gonococcal infection. Sex Transm Dis1997; 24(1): 32–37.
8.
BogaertsJTelloWMAkingeneyeJ, et al.Effectiveness of norfloxacin and ofloxacin for treatment of gonorrhoea and decrease of in vitro susceptibility to quinolones over time in Rwanda. Genitourin Med1993; 69(3): 196–200.
9.
Ministry of Health and Rwanda. Ro. National Guidelines for Prevention and Management of HIV and STIs2016.
10.
Ministry of Health and Rwanda. Ro. National guidelines for and management of viral hepatitis b, c and sexually transmitted infections2019.
11.
CDC. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014. MMWR Recomm Rep2014; 63(RR-02): 1–19.
12.
KaritaENsanzimanaSNdagijeF, et al.Implementation and operational research: evolution of couples’ voluntary counseling and testing for HIV in Rwanda: from research to public health practice. J Acquired Immune Defic Syndr2016; 73(3): e51–e58.
13.
MazzeiAIngabireRMukamuyangoJ, et al.Community health worker promotions increase uptake of long-acting reversible contraception in Rwanda. Reprod Health2019; 16(1): 75.
14.
IngabireRNyombayireJHoaglandA, et al.Evaluation of a multi-level intervention to improve postpartum intrauterine device services in Rwanda. Gates Open Res2018; 2(38): 38.
